| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5462740 | BAUSCH | Rectally-administered, epileptic-seizure-inhibiting composition |
Sep, 2013
(10 years ago) | |
Diastat Acudial is owned by Bausch.
Diastat Acudial contains Diazepam.
Diastat Acudial has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Diastat Acudial are:
- US5462740
Diastat Acudial was authorised for market use on 29 July, 1997.
Diastat Acudial is available in gel;rectal dosage forms.
The generics of Diastat Acudial are possible to be released after 17 September, 2013.
Drugs and Companies using DIAZEPAM ingredient
Market Authorisation Date: 29 July, 1997
Treatment: NA
Dosage: GEL;RECTAL
How can I launch a generic of DIASTAT ACUDIAL before it's drug patent expiration?
More Information on Dosage
DIASTAT ACUDIAL family patents
